From Digital Agents to Surgical Robots: How NVIDIA's Full-Stack Technology is Building a New Paradigm for Medical AI

Robotics and artificial intelligence technologies are profoundly transforming the healthcare industry, continuously enhancing efficiency and precision in disease diagnosis, surgical procedures, patient care, and hospital operations.

In this context, VCBeat specially invitesNVIDIA China Director of Healthcare Industry Applications, Ji YongnanwithLiu Weiping, Senior Director of Shanghai MicroPort MedBot (Group) Co., Ltd., onTuesday, April 21 at 15:00Online sharing, themedFrom Digital Agents to Surgical Robots: How NVIDIA’s Full-Stack Technology is Building a New Paradigm for Medical AI。

This live broadcast will delve intoInterpreting How NVIDIA Drives the Intelligent Transformation of Healthcare with Full-Stack Technology——From Physical AI systems capable of performing high-precision operations and alleviating clinical workforce pressures, to digital agents that integrate multimodal data to support preoperative planning and provide real-time intraoperative assistance.

NVIDIA will also share its latest strategic initiatives in medical artificial intelligence, detailing how its end-to-end technology ecosystem—spanning cutting-edge computing hardware, AI factories, and next-generation simulation platforms—provides comprehensive support for the research, development, and application of physical robots and digital twin systems. You will gain insights into how these technologies convergePerception, Cognition, Planning, Control, and Generative Reasoning Capabilities, facilitating the development of next-generation intelligent medical devices that are truly deployable in clinical settings.

Additionally, this live stream will also bringMicroPort® RoboticsFrontline Practice Sharing: Analyzing How MedTech Companies LeverageNVIDIA Tool Ecosystem, accelerate system development and enhance the intelligence level of products, thereby promoting the transition of autonomous medical capabilities from technology to clinical practice.

Scan the QR code in the poster below to register for the live stream.

Live Stream Time:April 21, 2026 (Tuesday) 15:00

Live Broadcast Topic:From Digital Agents to Surgical Robots: How NVIDIA’s Full-Stack Technology Is Building a New Paradigm for Medical AI

Live Stream Content:

1. How Robotics and AI Are Reshaping the Entire Healthcare Process to Enhance Efficiency in Diagnosis, Surgery, Nursing, and Operations

2. How NVIDIA Technology Is Driving Healthcare Transformation: From Physical AI Performing Precision Operations to Digital Agents Assisting Decision-Making

3. Interpretation of NVIDIA’s Latest Full-Stack Technology: Covering Cutting-Edge Hardware, AI Factories, and the Next-Generation Simulation Platform

4. How Medical Developers Can Accelerate R&D, Enhance System Intelligence, and Drive the Implementation of Autonomous Healthcare Based on the NVIDIA Ecosystem

· Building an Autonomous Surgical Intelligence Platform Based on the NVIDIA Technology Stack

· Generate Computer Surgery Data and Videos Using Cosmos-H

· Building a Virtual Surgical Space Based on Isaac for Healthcare

Dr. Yongnan Ji 

Director of Healthcare Industry Applications, NVIDIA China

Dr. Ji Yongnan is responsible for the implementation of NVIDIA’s technology platform within China’s healthcare industry. Prior to joining NVIDIA, he worked on the research, development, and deployment of AI algorithms and applications at companies and institutions including Tencent, GE Healthcare, Toshiba Medical Systems, and Samsung Research. Dr. Ji earned his degree from the University of Nottingham in the United Kingdom. He is an expert in medical imaging and artificial intelligence applications, having authored dozens of academic papers and core patents spanning interdisciplinary fields such as medical imaging and AI-driven image analysis.

Dr. Weiping Liu

Senior Director, Shanghai MicroPort MedBot (Group) Co., Ltd.

Dr. Liu Weiping oversees the research and development of image-guided navigation and artificial intelligence products at MicroPort MedBot. He possesses 13 years of experience in the R&D and management of medical imaging, surgical navigation, artificial intelligence, and surgical robotics within the industry. He has previously engaged in the development of intelligent algorithms and clinical applications at Philips Research China, Shanghai Siemens Medical Devices, and Fosun Group’s Xingmai Technology. Dr. Liu led the development of intelligent diagnostic systems for pulmonary nodules, coronary arteries, FFRCT, and stroke. He has conducted R&D in the field of surgical robotics, completing the development of multiple planning and navigation products for interventional robots, and has performed numerous ex vivo and animal experiments on automated surgery in the realm of embodied AI. He earned his Ph.D. from the Department of Automation, specializing in Pattern Recognition and Intelligent Systems, at the School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University. Dr. Liu is an expert in medical imaging and AI applications. He was awarded the title of Senior Engineer (Professional) in the field of Artificial Intelligence under the Shanghai Engineering Series in 2019. He has published dozens of academic papers and core patents covering interdisciplinary fields such as medical imaging, artificial intelligence, computer vision, and surgical robotics.

“Insights into Relativity” is a sub-column of VCBeat’s “China Innovative Medical Asset Living Room,” focusing on frontier hotspots and underlying logic in innovative medical asset transactions. This column brings together renowned experts from the fields of industry investment, industrial M&A, and technological innovation to share in-depth insights on transaction trends and model innovations in core sectors such as innovative drugs, high-end medical devices, and digital health.

Featuring “Expert Insights + Hot Topic Analysis,” this column provides strategic, financial, and industrial buyers with forward-looking deal strategies and trend assessments through in-depth interpretations of industry hotspots by experts and detailed breakdowns of classic transaction cases. It aims to help them accurately seize opportunities and scientifically mitigate risks in innovative asset transactions, building a professional knowledge platform that integrates “expert wisdom” with “hotspot insights.”